Unlike full hGH, AOD9604 selectively promotes fat breakdown (lipolysis) without affecting IGF-1 levels or causing hyperglycemia, which makes it a safer alternative for targeting obesity-related concerns
Unlike HGH, AOD-9604 does not affect insulin-like growth factor 1 (IGF-1) levels, meaning it does not have the same potential side effects as HGH, such as promoting cell growth or affecting blood sugar levels
While Medicare provides coverage under specific conditions, the rules are stricter than many expect, and costs can vary significantly based on the type of coverage and medical necessity, making it essential to stay informed about eligibility and documentation requirements
AOD-9604 5 mg is supplied as a high-purity lyophilized peptide research compound intended exclusively for scientific and laboratory applications
5-Amino-1MQ balances it, preserving NAD+, improving energy use, repair, fat burning, and inflammation control.[28][29] This inhibition also promotes white-to-brown fat conversion, enhancing thermogenesis and calorie burn
Changs recommendations